• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Google’s Pixel 4 will Include a Radar Sensor — Here’s Why That Could Matter for Health

Share:

October 23, 2019

A proof of concept prototype has already used the same Project Soli sensor to measure blood glucose.

At its Made By Google unveiling event in New York City today, Google announced that its Pixel 4 phone will be the first mobile phone with a radar sensor. It’s the first public rollout of the company’s Project Soli, an experimental, radar-based gesture tracker co-developed with Infineon.

When VP of Product Management Sabrina Ellis announced the Pixel 4’s motion-sensing feature, she showed off applications that allow users to swipe and dismiss notifications without touching the phone, or wave to an animated Pikachu who waves back.

The company is also aware of potential privacy concerns, so the radar feature is entirely contained on the phone — and never transmitted elsewhere.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

WHY IT MATTERS

Today’s announcement was not around health, except for a quick reference to “personal wellness” as part of Google’s future plans for the technology. However, there’s more reason to think health applications could be around the corner.

For one thing, digital health has a long history of exploring gesture tracking, largely via the now-defunct Microsoft Kinect and similar sensors. The technology has applications in physical therapy, sterile controls for surgeons and noninvasive health monitoring, among other things.

In fact, last year researchers from the University of Waterloo have described a proof-of-concept system that uses Google’s Soli to track concentrations of glucoses within a solution. With further investigation and adjustment, this prototype technology could potentially be implemented for diabetes patients as a novel noninvasive approach to managing blood glucose levels.

That’s not to say that out of the box a Pixel 4 will be able to noninvasively monitor blood glucose. But it does demonstrate the potential of the underlying technology.

WHAT’S THE TREND

The 2017 discontinuation of Kinect was a blow for healthcare use cases of gesture tracking, but not a fatal one. We spoke two years ago with a handful of companies in that space who were still going strong. And earlier this year, Microsoft announced the technology is making a comeback.

But moving the technology to a phone is significant. If this technology becomes part of the table stakes of mobile devices, it will open up new possibilities for scale for companies that use gesture tracking. This could include companies like AI.Cure, which currently use the phone’s camera to hold users accountable for medication adherence, or Klue, which currently uses wearables to monitor eating and drinking behaviors as a proxy for tracking calorie intake.

ON THE RECORD

“Radar’s been around for a long time and it’s still one of the best ways to sense motion. It’s precise, it’s low-power, and it’s fast. … But radar sensors have always been way too big to fit in a phone. So we shrank it down into a tiny chip,” Ellis said at the event. “The Soli team is working on a wide range of helpful new features, from gaming to personal wellness.”

Source: MobiHealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • CORRECTING and REPLACING Vim, a Healthcare Platform for Health Plan-provider Collaboration, Raises $24 Million in Series B Financing Led by Optum Ventures and Premera Blue CrossCORRECTING and REPLACING Vim, a Healthcare Platform for Health Plan-provider Collaboration, Raises $24 Million in Series B Financing Led by Optum Ventures and Premera Blue Cross
  • Siemens Healthineers, Hamilton Health Sciences Form $270M Imaging PartnershipSiemens Healthineers, Hamilton Health Sciences Form $270M Imaging Partnership
  • GE Healthcare and Microsoft Partner to Help Hospitals Fight COVID-19GE Healthcare and Microsoft Partner to Help Hospitals Fight COVID-19
  • Cigna still expecting Express Scripts deal to happen by year-endCigna still expecting Express Scripts deal to happen by year-end
  • FFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distributor of YCANTH™, the First FDA Approved Treatment for Molluscum ContagiosumFFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distributor of YCANTH™, the First FDA Approved Treatment for Molluscum Contagiosum
  • Tusk Therapeutics to be acquired by RocheTusk Therapeutics to be acquired by Roche
  • Former Shire Team Launches OncoOne with $14 Million+ Series AFormer Shire Team Launches OncoOne with $14 Million+ Series A
  • Bruker extends microscopy offering with JPK acquisitionBruker extends microscopy offering with JPK acquisition

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications